Table 1.

Rate of fertility services among male reproductive-aged cancer patients.

	Entire Cohort		Fertility Service^
	N	%	N	%	P-value	aRR (95%CI)#
All	3648	100.0	340	9.3
Age (years)					<0.0001
≤35	2389	40.4	274	11.5		1.76 (1.33, 2.34)**
36–40	1259	21.3	66	5.2		Referent
Cancer					<0.0001
Testicular Cancer	2610	71.6	302	11.6		3.31 (2.22, 4.92)**
Colorectal Cancer	939	25.7	32	3.4		Referent
Prostate Cancer	99	2.7	6	6.1		3.14 (1.28, 7.70)*
Health insurance					<0.0001
Medicaid	285	7.8	2	0.7		Referent
Commercial	3363	92.2	338	10.1		11.58 (2.10, 63.69)*
Region					<0.0001
Northeast	622	17.1	100	16.1		1.85 (1.41, 2.45)**
North Central	783	21.5	87	11.1		1.30 (0.98, 1.74)
South	1209	33.1	104	8.6		Referent
West	694	19.0	43	6.2		0.65 (0.45, 0.92)*
Unknown	340	9.3	6	1.8		0.38 (0.08, 1.70)
MSA					<0.0001
No	418	11.5	31	7.4		Referent
Yes	2881	79.0	300	10.4		1.36 (0.94, 1.97)
Unknown	349	9.6	9	2.6		3.08 (0.94, 10.06)
Elixhauser comorbidity					0.0133
0	3121	85.6	309	9.9		Referent
1	348	9.5	20	5.8		0.80 (0.51, 1.27)
≥2	179	4.9	11	6.2		1.10 (0.59, 2.03)
Year of surgery					0.0963
2008–2009	644	17.7	52	8.1		Referent
2010–2011	881	24.2	81	9.2		1.07 (0.76, 1.52)
2012–2013	886	24.3	70	7.9		0.96 (0.67, 1.38)
2014–2015	742	20.3	81	10.9		1.34 (0.94, 1.91)
2016–2017	495	13.6	56	11.3		1.49 (1.01, 2.20)*
Radiotherapy					0.1664
No	2865	78.5	277	9.7		Referent
Yes	783	21.5	63	8.1		1.30 (0.98, 1.73)
Chemotherapy					0.0022
No	1866	51.2	147	7.9		Referent
Yes	1782	48.9	193	10.8		1.81 (1.45, 2.27)**

^{^}Fertility evaluation 4.1%, fertility preservation 7.8%. Some patients (2.6%) had both fertility evaluation and preservation.

^#aRR: Adjusted risk ratio from multivariable log-linear model.

^*P-value < 0.05.

^**P-value < 0.0001.